XML 16 R5.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
Common Stock Outstanding
Additional Paid in Capital
Accumulated Other Comprehensive Income (Loss)
Retained Earnings (Accumulated Deficit)
Total
Balance at Mar. 31, 2021 $ 737 $ 8,946,872 $ 21,838 $ 972,401 $ 9,941,848
Balance (in shares) at Mar. 31, 2021 7,374,665        
Restricted stock award $ 3 (3)      
Restricted stock award (in shares) 30,000        
Issuance of common stock $ 1 34,999     35,000
Issuance of common stock (in shares) 5,000        
Issuance of warrants   46,256     46,256
Common stock issued for acquired business $ 37 2,268,963     2,269,000
Common stock issued for acquired business (shares) 366,515        
Proceeds from sale of common stock, net $ 80 3,187,502     3,187,582
Proceeds from sale of common stock, net (in shares) 800,682        
Net loss       (349,834) (349,834)
Foreign currency translation adjustment     $ (21,838)   (21,838)
Stock-based compensation   155,754     155,754
Balance at Mar. 31, 2022 $ 858 14,640,343   622,567 15,263,768
Balance (in shares) at Mar. 31, 2022 8,576,862        
Net loss       (979,006) (979,006)
Stock-based compensation   109,079     109,079
Stock issued for contingent consideration $ 1 56,309     56,310
Stock issued for contingent consideration (in shares) 9,127        
Stock award nonemployee directors $ 2 143,998     144,000
Stock award nonemployee directors (in shares) 25,000        
Stock split fractional share round up (in shares) 2,419        
Balance at Mar. 31, 2023 $ 861 $ 14,949,729   $ (356,439) $ 14,594,151
Balance (in shares) at Mar. 31, 2023 8,613,408